Universita di Verona

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

Clinical Trials↗

All sponsored trials (all statuses)

Activity

Recent Activity

Last 14 days

Jul 14, 2026

Completed

"Fear of Falling": i Determinanti Clinici e Psicologici Nel Paziente Neurologico. Studio Osservazionale di Tipo Trasversale

Jul 7, 2026

Completed

Impact of Muscle and Tendon Dysfunction on the Mechanics of Muscle Contraction and Locomotion Capacity in People With Type 2 Diabetes Mellitus, and Efficacy of a Passive Stretching Training Program to Counteract These Alterations

Jul 3, 2026

Recruiting

Neuropsychology and Personality: Personality Traits as a Variable in the Recovery of Patients With Acquired Brain Injury

Earlier

Feb 1, 2026TrialDiscontination of Antidepressants in Remitted Depression

Jul 15, 2024TrialFilgotinib Effect on Proteomic Profile and Micro-RNA Expression in Patients With Active Rheumatoid Arthritis (RA)

Feb 1, 2023TrialNivolumab/Ipilimumab and Chemotherapy Combination in Advanced NSCLC Patients With HIV, HBV, HCV and Long Covid Syndrome

Jun 1, 2022TrialINcobotulinumtoxina in ChIldren Upper and Lower Limb sPasticITy (INCIPIT)

Aug 1, 2020TrialMethotrexate Versus Secukinumab Safety in Psoriasis Patients With Metabolic Syndrome

3 more events

Mar 20, 2019TrialSecukinumab Efficacy Without the Initial Loading Dose in Patients With Psoriasis

Jan 1, 2019TrialPatient's Preferences About Subcutaneous or Vaginal Progesterone Administration for Luteal Phase Support

Mar 28, 2018TrialPain in Parkinson's Disease With Motor Fluctuations.

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)